Pelican Cancer Foundation, The Ark, Dinwoodie Drive, Basingstoke, Hampshire, RG24 9NN | +44 (0)1256

314 746 | admin@pelicancancer.org | www.pelicancancer.org | Registered charity 1141911 (England

and Wales), company limited by guarantee 7264864 (England) | Registered office as above.

6 CPD credits awarded by BAUS

Certificates will be emailed to everyone

after the workshop

Pelican Cancer Foundation (Pelican stands for Pelvic Liver Cancer), is based in

Basingstoke and has been seed funding colorectal and prostate cancer research for

25 years. Our ethos is helping clinicians make incremental changes in practice that

help their patients live better lives for longer. The charity has run four national

programmes for colorectal multidisciplinary teams and TIPTOP is our first national

urology programme.

TIPTOP is funded with charity funds, industry sponsorship and charitable donations

including a £30,000 grant thanks to a bowel cancer patient).

This meeting has been part sponsored by Ferring Pharmaceuticals’ Ipssen Lts and

Aspire Pharma.

Greater Manchester Cancer is the organisation coordinating cancer care across

Greater Manchester and Eastern Cheshire, from prevention, screening, primary care

through to secondary care and hospice/palliative care. This has led to the formation

of a dedicated regional cancer plan (2015-20) which is now in the delivery phase.

Tuesday, 12th February 2019 The LifeCentre 235 Washway Road Sale M33 4BP

We would like to thank all the faculty who have generously given their time: Dr Francesco Giganti, Radiologist University College London Hospital

Mr Simon Bott, Consultant Urological Surgeon Frimley Park Hospital

Urology MDT Lead

Mr Daniel Burke, Consultant Urological Surgeon Manchester Royal Infirmary

Mr Philip Cornford, Consultant Urological Surgeon Royal Liverpool University Hospital

Ms Sarah Crane, Chief Executive Pelican Cancer Foundation

Mr James Dyer, Consultant Urological Surgeon Stockport NHS Foundation Trust

Newly appointed urologist to Stepping Hill

Prof Richard Hindley, Consultant Urological Surgeon Basingstoke & North Hampshire Hospital Honorary Consultant at UCLH & MDT Lead for BNHFT

Dr Maryna Brochwicz-Lewinski, Consultant Radiologist

Stockport NHS Foundation Trust

Mr Satish Maddineni, Consultant Urological Surgeon Salford Royal NHS Foundation Trust

Ms Linda Martin, Urology Specialist Nurse Stockport NHS Foundation Trust

Urology specialist nurse at Stockport since 1995

Prof Caroline Moore, Consultant Urological Surgeon University College London Hospital

Miss Helen Saunders, Senior Programme Manager

UCLH Cancer Collaborative

Prof David Shackley, Consultant Urological Surgeon Salford Royal NHS Foundation Trust Medical Director of Greater Manchester Cancer Clinical lead in cancer at MAHSC (Manchester Academic Health Science Centre)

Dr Murali Varma, Consultant Histopathologist

University Hospital of Wales, Cardiff, UK Chairman, British Association of Urological Pathologists.

Co-author of RCP datasets for Prostate Cancer & Cancers of the Urinary Collecting System

Faculty Programme Aims: - To bring together local and regional teams to discuss the prostate cancer pathway - Explore local solutions and collaborations to help teams and patients

08.30 Coffee and Registration (Speakers)

09.00 Welcome Ms Sarah Crane

Chair: Mr Philip Cornford

09.05 Case study & Panel: Prof Noel Clarke, Dr Alistair Cowie

Miss Ling Lee, Mr Amar Mohee, Dr Andy Counsell, Dr Mike Scott Mr Satish Maddineni

Chair: Prof Richard Hindley

09.45 Cancer Alliance – local priorities and resources Prof David Shackley

10.00 Management perspective Miss Helen Saunders

10.15 Reducing timelines in a time of increased demands Mr Simon Bott

10.30 Discussion

10.40 Coffee

Chair: Mr Daniel Burke

11.10 Triage approaches for a timed diagnostic pathway Prof Caroline Moore

11.30 Discussion

11.35 Pre-workshop case study feedback Mr Simon Bott

Chair: Prof Caroline Moore

11.50 mpMRI standards: ruling in and ruling out malignant disease and

reporting protocols Dr Francesco Giganti

12.20 Discussion

12.30 Lunch

Chair: Mr Philip Cornford

13.30 Prostate MRI the good, the bad and the ugly Dr Maryna Brochwicz-Lewinski

13.55 Discussion

Chair: Mr Simon Bott

14.00 PROMIS & PRECISION – what has changed? Mr James Dyer

14.10 Using mpMRI to decide who and how to biopsy Prof Caroline Moore

Chair: Mr Satish Maddineni

14.25 Pathology in the pathway Dr Murali Varma

14.45 Gleason 6 - has there been a grade shift? Prof Richard Hindley

15.00 Discussion

15.05 Coffee

Chair: Mr Daniel Burke

15.20 Patient’s perspective and priorities Ms Linda Martin

15.35 Will prostate cancer screening rise from the ashes? Mr Philip Cornford

15.50 Next steps Prof David Shackley

16.00 Summary Mr Satish Maddineni